Prothena | PRTA - Assets

Stock Price
8.85
Daily Change
0.07 0.80%
Monthly
-2.75%
Yearly
-40.12%
Q1 Forecast
8.55

Prothena reported $352.63M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acadia Pharmaceuticals USD 1.33B 105.22M Sep/2025
Agios Pharmaceuticals USD 1.39B 85.53M Sep/2025
ALKERMES USD 2.33B 76.7M Sep/2025
Alnylam Pharmaceuticals USD 4.85B 285.64M Sep/2025
Amgen USD 90.14B 2.24B Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Exelixis USD 2.82B 145.47M Sep/2025
Incyte USD 6.33B 509M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
MacroGenics USD 270.76M 25.34M Sep/2025
Neurocrine Biosciences USD 4.27B 375.9M Sep/2025
Prothena USD 352.63M 46.44M Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Ultragenyx Pharmaceutical USD 1.19B 115.82M Sep/2025
Vertex Pharmaceuticals USD 24.86B 825.6M Sep/2025